Literature DB >> 15753666

Investigation of loss of heterozygosity and SNP frequencies in the RET gene in papillary thyroid carcinoma.

L A Stephens1, N G Powell, J Grubb, S J Jeremiah, J A Bethel, E P Demidchik, T I Bogdanova, M D Tronko, G A Thomas.   

Abstract

In both medullary carcinoma and papillary carcinoma of the thyroid, altered expression of the RET gene is implicated in tumorigenesis. Recent studies suggest that loss of heterozygosity (LOH) at the G691S SNP may be associated with tumors from patients with a history of radiation exposure. We investigated LOH for three RET SNPs (G691S, S904S, and L769L) in tumor and normal tissue from 46 patients from Ukraine and Belarus who were exposed to radioactive fallout following the Chernobyl nuclear accident and were operated for papillary thyroid carcinoma between 1995 and 2000. Normal tissue from 28 patients was heterozygous for at least one SNP; DNA from the corresponding tumor samples was also heterozygous, indicating that no LOH had taken place. To assess SNP frequencies in a radiation-associated thyroid cancer cohort, we investigated a further 68 unpaired post-Chernobyl samples. For G691S, there was considerable deviation from Hardy-Weinberg equilibrium; more detailed analysis showed that this was linked to age at onset of disease. Among younger patients, the distribution of genotypes conformed to Hardy-Weinberg equilibrium; among older patients, we observed marked deviation (p = 0.0072), with significant over-representation of the rare S allele relative to the younger groups (Fisher's exact, p = 0.0233). This suggests that SNPs in the RET oncogene may play a role in sporadic papillary thyroid carcinoma.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15753666     DOI: 10.1089/thy.2005.15.100

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  5 in total

1.  BIRC5 promoter SNPs do not affect nuclear survivin expression and survival of malignant pleural mesothelioma patients.

Authors:  Julija Hmeljak; Nina Erčulj; Vita Dolžan; Izidor Kern; Andrej Cör
Journal:  J Cancer Res Clin Oncol       Date:  2011-08-23       Impact factor: 4.553

2.  Functional RET G691S polymorphism in cutaneous malignant melanoma.

Authors:  N Narita; A Tanemura; R Murali; R A Scolyer; S Huang; T Arigami; S Yanagita; K K Chong; J F Thompson; D L Morton; D S Hoon
Journal:  Oncogene       Date:  2009-06-29       Impact factor: 9.867

3.  Investigating the mechanisms of papillary thyroid carcinoma using transcriptome analysis.

Authors:  Jie Qiu; Wenwei Zhang; Qingsheng Xia; Fuxue Liu; Shuwei Zhao; Kailing Zhang; Min Chen; Chuanshan Zang; Ruifeng Ge; Dapeng Liang; Yan Sun
Journal:  Mol Med Rep       Date:  2017-08-24       Impact factor: 2.952

Review 4.  Genetic Polymorphism Predisposing to Differentiated Thyroid Cancer: A Review of Major Findings of the Genome-Wide Association Studies.

Authors:  Vladimir A Saenko; Tatiana I Rogounovitch
Journal:  Endocrinol Metab (Seoul)       Date:  2018-06

5.  Single nucleotide polymorphism rs17849071 G/T in the PIK3CA gene is inversely associated with follicular thyroid cancer and PIK3CA amplification.

Authors:  Jeffrey C Xing; Ralph P Tufano; Avaniyapuram Kannan Murugan; Dingxie Liu; Gary Wand; Paul W Ladenson; Mingzhao Xing; Barry Trink
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.